It’s hard to imagine the "Gladiator" himself feeling vulnerable, but Russell Crowe recently opened up about a physical toll ...

At a routine follow-up, her specialist was shocked - not just by her weight loss, but by a medical marker that had never ...

Janus Henderson Forty Fund returned 0.27% and the Russell 1000® Growth Index returned 1.12%. U.S. shares rose on positive ...

Researchers found that people taking GLP-1 medications faced a significantly higher risk of skeletal disorders.

A bariatric surgeon says the best way to boost your metabolism, help weight loss, dampen inflammation and live a happier and ...

New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

We have some refreshing news: Going gently may be the new way to get healthy. Forget harsh, exhausting weight-loss plans. Research in the Journal of Happiness and Health shows that replacing a ...

The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...

RIVKIN Aesthetics reports the rise of weight loss drugs like GLP-1 is reshaping aesthetics, with many new patients seeking ...

Experts warn the label is ‘more marketing than medical’; urge following evidence on nutritional recommendations for GLP-1 therapy.

A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain, on average, 60% of their lost ...